In short
When the nervous control of the bladder is damaged, the danger is to the kidneys. This guide explains the two functional patterns, why urodynamics is central, and how intermittent catheterisation protects renal function.
What this guide covers: Causes · Two functional patterns · Assessment · Treatment · Follow-up
Neurogenic bladder is the umbrella term for bladder and urethral dysfunction caused by disease of the nervous system. It produces lower urinary tract symptoms — frequency, urgency, incontinence, difficulty voiding — but the clinically important consequence is upstream: sustained high bladder pressures or incomplete emptying can damage the upper urinary tract and lead to renal failure.
The guiding principle of management is therefore not symptom relief alone. It is protection of renal function first, and improvement of continence and quality of life second.
Causes
Central nervous system causes include stroke, brain tumours, Parkinson disease, multiple sclerosis and spinal cord injury — the last of which interrupts the pathways coordinating detrusor contraction and sphincter relaxation. Peripheral causes include diabetic neuropathy, alcohol-related neuropathy, drug effects and pelvic surgical injury, notably after rectal cancer surgery. Congenital causes include spina bifida and meningomyelocele.
Two functional patterns
Storage-phase dysfunction covers overactivity of the detrusor, producing urgency, frequency and urge incontinence, and reduced or absent bladder sensation, which allows silent overfilling.
Voiding-phase dysfunction covers a detrusor that contracts too weakly — so the patient must strain or cannot void at all — and sphincter dysfunction, which may be spastic and obstruct outflow or incompetent and cause leakage.
Assessment
Diagnosis combines history, symptom scoring, examination and investigations. The history covers neurological disease, trauma, surgery and diabetes, plus the timeline of urinary symptoms. Validated questionnaires such as the IPSS and the overactive bladder symptom score quantify the burden.
Examination is both neurological — perineal sensation, anal sphincter tone, lower limb power — and urological, checking for a palpable bladder and urethral abnormality.
Investigations start with urinalysis and culture, and ultrasound for bladder morphology, post-void residual and hydronephrosis. Urodynamics is the key test: cystometry, urethral pressure profilometry and uroflowmetry define exactly what the detrusor and the sphincter are doing, which is what determines safe treatment. Intravenous urography or CT urography evaluates the upper tract and excludes stones or tumours.
Treatment
Conservative management comes first. Clean intermittent catheterisation is the standard method for emptying a bladder that does not empty itself — it lowers intravesical pressure and reduces infection compared with an indwelling catheter. Indwelling catheters are reserved for patients who cannot perform intermittent catheterisation, and carry higher rates of infection, stone formation and urethral damage.
Medication is matched to the pattern. Antimuscarinics such as tolterodine or solifenacin suppress involuntary detrusor contraction in the overactive bladder. Cholinomimetic agents are used where the detrusor is underactive, though their role is limited.
Rehabilitation includes pelvic floor muscle training to improve continence and bladder training with scheduled drinking and voiding to increase capacity and compliance.
Surgery is reserved for specific situations: augmentation cystoplasty where the bladder is small or poorly compliant; sphincterotomy where sphincter spasm obstructs outflow; and urinary diversion where urethral voiding and intermittent catheterisation are both impossible.
Follow-up
Neurogenic bladder changes over time, so surveillance is part of treatment. Review typically includes symptom review, urinalysis, ultrasound and periodic urodynamics every three to six months, extended in stable patients and shortened when the picture is shifting. The purpose of that schedule is to detect deteriorating storage pressures or new upper-tract dilatation before renal function is lost.
Practical point for patients
Ask what your post-void residual is, whether your upper tracts are being imaged, and how often urodynamics will be repeated. Those three questions track the things that actually determine long-term outcomes.
Sources and further reading
One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.
General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.

